• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.


    Memorandum to All Behavioral Health Treatment Programs - From Renee Webster, Assistant Director, OHCQ and Kathleen Rebbert-Frankling, Acting Director, ADAA - Regarding:  Point of Care Toxicology Testing (April 4, 2013)

    Although the following paragraph is mention in the letter blast, many phone calls have been received asking which two applications are required.

    1. The program must complete two applications:  A State Compliance Application requesting a Letter of Exception and an application for a CLIA (Clinical Laboratory Improvement Amendments) certificate of waiver for the Department of Health and Human Services, Center for Medicaid and Medicare Services (CMS).  The applications can be obtained at www.dhmh.maryland.gov/ohcq/.

    For convenience sake, the two applications are listed below.  On the CLIA application you need to select CLIA waiver on the first page.  On the state application use schedule B on the test menu page and select the checkbox - Urine or saliva drug or alcohol for approved counselors.

    Per the new regs the named director on both of the applications should meet the following:

    C)  Be clinical staff who:

    (i)  Meets the qualifications set for in COMAR;

    (ii)  Is employed by a substance abuse treatment program that is certified or accredited in accordance with COMAR; and

    (iii) Is authorized to order tests to detect the presence of controlled dangerous substances on patients enrolled in the substance abuse treatment program.

    Instructions for Completion of State Compliance Application

    Clinical Laboratory Improvement Amendments (CLIA) Application for Certification

    ** Please mail both completed applications along with the director's diploma and copy of current license to:

    Lab Licensing Department
    55 Wade Avenue, Bland Bryant Building
    Catonsville, MD  21228